| abstract |
A protein which is capable of inhibiting epidermal growth factor-induced cellular proliferation is disclosed, as well as a method of obtaining it from a host cell, and a method of obtaining the same in purified form. Therapeutic uses of, and pharmaceutical compositions containing, EGFI, TC4, and CDC25 are also described. In addition, the use of EGFI-related gene therapy is described. |